Three Year Outcomes After Shoulder Arthroplasty

ClinicalTrials.gov ID: NCT07815535

Public ClinicalTrials.gov record NCT07815535. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 12, 2026, 8:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluating Three-Year Outcomes For Total Versus Reverse Shoulder Arthroplasty

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this multicenter observational cohort study is to evaluate three-year outcomes in adults who underwent anatomic or reverse total shoulder arthroplasty using a contemporary shoulder implant system. The main questions it aims to answer are: Are three-year patient-reported outcomes after anatomic total shoulder arthroplasty comparable to those after reverse total shoulder arthroplasty? How often do the implants used during surgery differ from the preoperative three-dimensional (3D) surgical plan, and are these differences associated with patient outcomes, complications, or revision surgery? Researchers will compare patient-reported outcomes, function, complications, and revision rates between patients who underwent anatomic and reverse total shoulder arthroplasty. Researchers will review participant existing medical records and surgical information. Participants whose two- or three-year outcome measures are not available may be asked to complete a one-time questionnaire by telephone or secure electronic survey. No treatments or additional clinical procedures will be performed as part of this study.

Study identification

NCT ID: NCT07815535
Recruitment status: Not yet recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Vani Sabesan; Other
Enrollment: 300 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2026
Primary completion: Dec 31, 2027
Completion: Jul 31, 2028
Last update posted: Sep 10, 2026

2026 – 2028

United States locations

U.S. sites: 5
U.S. states: 5
U.S. cities: 5

Facility	City	State	ZIP	Site status
Sabesan Orthopaedics Research Inc	Atlantis	Florida	33462	—
Steindler Orthopaedic Clinic	North Liberty	Iowa	52317	—
Kansas City Orthopaedic Alliance	Leawood	Kansas	66224	—
Somers Orthopaedic Surgery & Sports Medicine Group	Carmel	New York	10512	—
Tennessee Orthopaedic Alliance	Columbia	Tennessee	38401	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07815535, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 10, 2026 · Synced Sep 12, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07815535 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →